| Prognostic value of deep sequencing method for minimal residual disease detection in multiple myeloma J Martinez-Lopez, JJ Lahuerta, F Pepin, M González, S Barrio, R Ayala, ... Blood, The Journal of the American Society of Hematology 123 (20), 3073-3079, 2014 | 496 | 2014 |
| Exome sequencing reveals novel and recurrent mutations with clinical impact in blastic plasmacytoid dendritic cell neoplasm J Menezes, F Acquadro, M Wiseman, G Gómez-López, RN Salgado, ... Leukemia 28 (4), 823-829, 2014 | 190 | 2014 |
| Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation A Alvarez-Larrán, A Pereira, P Guglielmelli, JC Hernández-Boluda, ... haematologica 101 (8), 926, 2016 | 163 | 2016 |
| Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies JM Sanchez‐Pina, M Rodríguez Rodriguez, N Castro Quismondo, ... European Journal of Haematology 105 (5), 597-607, 2020 | 106 | 2020 |
| Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy E Barragán, P Montesinos, M Camos, M González, MJ Calasanz, ... Haematologica 96 (10), 1470, 2011 | 74 | 2011 |
| High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms I Rapado, S Grande, E Albizua, R Ayala, JA Hernández, M Gallardo, ... The Journal of Molecular Diagnostics 11 (2), 155-161, 2009 | 74 | 2009 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 73 | 2023 |
| Obesity is an independent risk factor for pre-transplant portal vein thrombosis in liver recipients R Ayala, S Grande, R Bustelos, C Ribera, A García-Sesma, C Jimenez, ... BMC gastroenterology 12, 1-6, 2012 | 72 | 2012 |
| Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma J Martinez-Lopez, B Sanchez-Vega, S Barrio, I Cuenca, Y Ruiz-Heredia, ... Leukemia 31 (6), 1446-1449, 2017 | 62 | 2017 |
| Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular response P Martínez‐Sánchez, L Montejano, ME Sarasquete, R García‐Sanz, ... British journal of haematology 142 (5), 766-774, 2008 | 62 | 2008 |
| Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemia JC Hernández-Boluda, E Arellano-Rodrigo, F Cervantes, ... Annals of hematology 94, 911-918, 2015 | 61 | 2015 |
| Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases I Rapado, E Albizua, R Ayala, JA Hernández, L Garcia-Alonso, S Grande, ... Annals of hematology 87, 741-749, 2008 | 56 | 2008 |
| Minimal residual disease monitoring with next-generation sequencing methodologies in hematological malignancies R Sánchez, R Ayala, J Martínez-López International Journal of Molecular Sciences 20 (11), 2832, 2019 | 52 | 2019 |
| Mutations in the DNA methylation pathway and number of driver mutations predict response to azacitidine in myelodysplastic syndromes MT Cedena, I Rapado, A Santos-Lozano, R Ayala, E Onecha, M Abaigar, ... Oncotarget 8 (63), 106948, 2017 | 51 | 2017 |
| Clinical significance of Gata‐1, Gata‐2, EKLF, and c‐MPL expression in acute myeloid leukemia RM Ayala, J Martínez‐López, E Albízua, A Diez, F Gilsanz American journal of hematology 84 (2), 79-86, 2009 | 47 | 2009 |
| Breast Cancer–Specific mRNA Transcripts Presence in Peripheral Blood After Adjuvant Chemotherapy Predicts Poor Survival Among High-Risk Breast Cancer Patients Treated With High … M Quintela-Fandino, JM López, R Hitt, S Gamarra, A Jimeno, R Ayala, ... Journal of clinical oncology 24 (22), 3611-3618, 2006 | 45 | 2006 |
| A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia E Onecha, M Linares, I Rapado, Y Ruiz-Heredia, P Martinez-Sanchez, ... haematologica 104 (2), 288, 2019 | 42 | 2019 |
| Correlation of WT1 expression with the burden of total and residual leukemic blasts in bone marrow samples of acute myeloid leukemia patients JM Alonso-Dominguez, M Tenorio, D Velasco, L Abalo, S Lozano, ... Cancer Genetics 205 (4), 190-191, 2012 | 39 | 2012 |
| Recipient and donor thrombophilia and the risk of portal venous thrombosis and hepatic artery thrombosis in liver recipients R Ayala, J Martínez-López, T Cedena, R Bustelos, C Jimenez, E Moreno, ... BMC gastroenterology 11, 1-9, 2011 | 38 | 2011 |
| Real‐time PCR quantification of haematopoietic chimerism after transplantation: a comparison between TaqMan and hybridization probes technologies J MARTINEZ‐LOPEZ, A Crooke, S Grande, R Ayala, ... International Journal of Laboratory Hematology 32 (1p1), e17-e25, 2010 | 38 | 2010 |
